Das Technology Qiyun Completes Strategic Investment in DaJia Medical to Forge New Landscape in Healthcare Big Data

VCBeat (WeChat ID: vcbeat) has learned that on February 24, Shenzhen Dashi Qiyun Intelligent Medical Co., Ltd. (hereinafter referred to as “Qiyun”) and Shanghai Daijia Medical Information System Co., Ltd. (hereinafter referred to as “Daijia Medical”) held an on-site signing ceremony in Shanghai, officially announcing that Qiyun has completed its strategic investment in Daijia Medical and achieved full ownership.

Dashi Qiyun is a leading enterprise in the construction and operation of China’s health and medical big data, as well as a pioneer and leader in the “platform construction plus operation” model for city-level big data initiatives. Daijia Medical is one of China’s earliest and largest providers of medical imaging systems, boasting over 20 years of technical expertise in imaging data and serving more than 300 high-quality clients among Grade A tertiary hospitals. Through this strategic partnership, Dashi Qiyun and Daijia Medical have established a complete data loop spanning from textual big data to imaging big data. By fully integrating their respective strengths in R&D, products, branding, and marketing, the two parties will deliver comprehensive, high-quality capabilities for the construction and operation of health and medical big data, covering both city-level and hospital-level applications.

Mr. Huang Deqiang, Chairman of Dashi Qiyun (center right), and Mr. Qian Weijia, Vice Chairman of Daijia Medical (center left), pose for a photo after signing the agreement

Leveraging this powerful synergy, Dashi Qiyun will fully integrate Daijia Medical’s nationally leading imaging products and technical service capabilities. Building upon the Dashi Qiyun Health and Medical Big Data Platform, the company will enhance the application of regional imaging systems, promote mutual recognition of laboratory and imaging test results across regions, provide cities with high-quality regional cloud imaging operational services, and deliver more convenient and affordable healthcare services to residents.

Meanwhile, Daijia Medical will build an AI-based comprehensive service platform for medical imaging by integrating Dashi Qiyun Health’s big data capabilities with its traditional medical imaging services, thereby delivering more valuable solutions to users.

Shenzhen Dashi Qiyun Intelligent Medical Co., Ltd., formerly the Smart Healthcare Division of Das Intellitech (Stock Code: 002421), is committed to its mission of “Healthy Cities, Accessible to All.” Aiming to harness massive data and diverse application scenarios, the company provides government authorities, medical institutions, residents, and other relevant organizations with services encompassing the planning, construction, and full-lifecycle operation of health information and big data systems.

Since 2015, Dashi Qiyun has taken the lead in Anhui Province by investing in and constructing a health and medical big data platform through Public-Private Partnership (PPP) models. The Huainan Smart Healthcare Project stands as the only regional smart healthcare PPP demonstration project approved by the Ministry of Finance of China to date, and it achieved Level 4 Class A certification for standardization maturity in regional health information interoperability in 2019. Currently, Dashi Qiyun’s new-generation health and medical big data platform has been deployed in cities including Huainan, Baoding, Hengshui, and Suzhou, serving over 20 million residents across these four municipalities.

Shanghai Daijia Medical Information System Co., Ltd. (Daijia Medical), established in 1999, is one of the earliest companies in China engaged in healthcare informatization. The company specializes in software development, system integration, application consulting, sales, and services, providing comprehensive healthcare informatization solutions to various medical service institutions and health administrative departments.

Daijia Medical specializes in the field of healthcare informatization, boasting an R&D team of nearly 100 members, with professional technical personnel accounting for 70% of its total workforce. Committed to helping clients address the significant challenges encountered during digital transformation, and under the guidance of international experts with extensive industry experience, the company combines independent R&D with strategic partnerships with leading global medical IT organizations. This approach has enabled many of its products to achieve domestic and even international leading standards.